Velleca Mark A. Insider Trades

Insider Trading History

Track insider trading activity for Velleca Mark A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
PRESIDENT & CEO
Holding Value $1.26M 600,000 shares
Last Trade
Jan 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.54M 600,000 shares
$2.57
$2.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
PRESIDENT & CEO
Holding Value $1.05M 500,000 shares
Last Trade
Jan 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 500,000 shares
$2.52
$2.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
PRESIDENT & CEO
Holding Value $1.13M 537,000 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.61M 537,000 shares
$4.86
$2.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
PRESIDENT & CEO
Holding Value $2.1M 1,000,000 shares
Last Trade
Sep 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.55M 1,000,000 shares
$3.55
$2.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
PRESIDENT & CEO
Holding Value $97.7k 46,522 shares
Last Trade
Sep 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.7k 5,208 shares
$3.60
$2.10
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $831k 116,000 shares
Last Trade
Aug 08, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$120k 60,000 shares
$2.00
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $1.24M 173,286 shares
Last Trade
Aug 08, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 60,000 shares
$2.03
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $1.73M 242,286 shares
Last Trade
Aug 08, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 60,000 shares
$2.03
$7.16
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $86.8k 41,314 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.8k 8,929 shares
$2.10
$2.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $34.7k 16,500 shares
Last Trade
May 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30k 16,500 shares
$1.82
$2.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $68k 32,385 shares
Last Trade
Mar 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.8k 11,228 shares
$1.67
$2.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $44.4k 21,157 shares
Last Trade
Dec 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.6k 8,424 shares
$1.50
$2.10
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $410k 57,286 shares
Last Trade
Oct 18, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 15,000 shares
$11.38
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $831k 116,000 shares
Last Trade
Oct 18, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$176k 15,000 shares
$11.70
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $938k 131,000 shares
Last Trade
Oct 18, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 15,000 shares
$11.38
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $831k 116,000 shares
Last Trade
Sep 20, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$270k 20,000 shares
$13.50
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $974k 136,000 shares
Last Trade
Sep 20, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$285k 20,000 shares
$14.25
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $518k 72,286 shares
Last Trade
Sep 20, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$285k 20,000 shares
$14.25
$7.16
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $26.7k 12,733 shares
Last Trade
Sep 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.3k 4,294 shares
$2.62
$2.10
G1 Therapeutics
G1 Therapeutics GTHX
Director
Holding Value $831k 116,000 shares
Last Trade
Aug 16, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.01M 80,000 shares
$12.64
$7.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up